Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0GJ1E
|
|||
Former ID |
DNC009836
|
|||
Drug Name |
8-(4-bromophenyl)-N-hydroxy-8-oxooctanamide
|
|||
Synonyms |
CHEMBL319070; 8-(4-bromophenyl)-N-hydroxy-8-oxooctanamide; SCHEMBL3382402; RFYYZRFJBNAHCG-UHFFFAOYSA-N; BDBM50114817; n-hydroxy-7-(4-bromobenzoyl)heptanamide; 8-(4-Bromo-phenyl)-8-oxo-octanoic acid hydroxyamide
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C14H18BrNO3
|
|||
Canonical SMILES |
C1=CC(=CC=C1C(=O)CCCCCCC(=O)NO)Br
|
|||
InChI |
1S/C14H18BrNO3/c15-12-9-7-11(8-10-12)13(17)5-3-1-2-4-6-14(18)16-19/h7-10,19H,1-6H2,(H,16,18)
|
|||
InChIKey |
RFYYZRFJBNAHCG-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | 3D-QSAR studies of HDACs inhibitors using pharmacophore-based alignment. Eur J Med Chem. 2009 Jul;44(7):2868-76. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.